Market Research Logo

Tissue Sealants - Medical Devices Pipeline Assessment, 2018

Tissue Sealants - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Tissue Sealants - Medical Devices Pipeline Assessment, 2018 provides an overview of Tissue Sealants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Sealants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Sealants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Sealants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Tissue Sealants Overview
3 Products under Development
3.1 Tissue Sealants - Pipeline Products by Stage of Development
3.2 Tissue Sealants - Pipeline Products by Segment
3.3 Tissue Sealants - Pipeline Products by Territory
3.4 Tissue Sealants - Pipeline Products by Regulatory Path
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date
3.6 Tissue Sealants - Ongoing Clinical Trials
4 Tissue Sealants - Pipeline Products under Development by Companies
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development
4.2 Tissue Sealants - Pipeline Products by Stage of Development
5 Tissue Sealants Companies and Product Overview
5.1 Adhesys Medical GmbH Company Overview
5.2 Advanced Medical Solutions Group plc Company Overview
5.3 Aleo BME Inc Company Overview
5.4 Angiotech Pharmaceuticals Inc Company Overview
5.5 Baxter International Inc Company Overview
5.6 Biomedica Management Corp Company Overview
5.7 Boston University Company Overview
5.8 C. R. Bard Inc Company Overview
5.9 Calmare Therapeutics Inc Company Overview
5.10 Clemson University Company Overview
5.11 Cohera Medical Inc Company Overview
5.12 Covalent Medical, Inc. (Inactive) Company Overview
5.13 DSM Biomedical BV Company Overview
5.14 Elastagen Pty Ltd Company Overview
5.15 Ethicon Endo-Surgery Inc Company Overview
5.16 Gamma Therapeutics Inc Company Overview
5.17 GATT Technologies BV Company Overview
5.18 Gecko Biomedical Company Overview
5.19 Grifols SA Company Overview
5.20 Hemostasis LLC Company Overview
5.21 HyperBranch Medical Technology Inc Company Overview
5.22 Institute of Molecular Biology of Parana Company Overview
5.23 InVivo Therapeutics Corp Company Overview
5.24 Johns Hopkins University Company Overview
5.25 Kollodis BioSciences Inc Company Overview
5.26 Kuros Biosciences AG Company Overview
5.27 Laser Tissue Welding, Inc. Company Overview
5.28 LifeBond Ltd Company Overview
5.29 Medisse BV (Inactive) Company Overview
5.30 Pharming Group NV Company Overview
5.31 Polyganics BV Company Overview
5.32 Protein Polymer Technologies Inc (Inactive) Company Overview
5.33 Samyang Biopharmaceuticals Corp Company Overview
5.34 Sealantis Ltd. Company Overview
5.35 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.36 Surgical Sealants, Inc. Company Overview
5.37 Teijin Pharma Ltd Company Overview
5.38 Texas A&M University Company Overview
5.39 The Medicines Company Overview
5.40 Tissue Regenix Ltd Company Overview
5.41 University of Akron Company Overview
6 Tissue Sealants- Recent Developments
6.1 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO
6.2 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals
6.3 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.4 Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses
6.5 May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM
6.6 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends
6.7 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.8 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency
6.9 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
6.10 May 14, 2018: Cesca Therapeutics Reports First Quarter 2018 Financial Results
6.11 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.12 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales
6.13 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results
6.14 Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results
6.15 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018
6.16 Apr 25, 2018: Cohera Medical Awarded Patent on its Biodegradable Sealant Technology
6.17 Apr 25, 2018: The Medicines Company Reports First-Quarter 2018 Results
6.18 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results
6.19 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.20 Mar 27, 2018: The Medicines Company Announces Chief Financial Officer Transition
6.21 Mar 22, 2018: Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update
6.22 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement
6.23 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
6.24 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017
6.25 Mar 08, 2018: FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch
6.26 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
6.27 Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors
6.28 Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
6.29 Feb 01, 2018: Grunenthal Group receives FDA’s Expedited Access Pathway designation for VIVO
6.30 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results
6.31 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.32 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
6.33 Jan 19, 2018: Grunenthal Group receives CE-Certification for innovative surgical sealant
6.34 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience
6.35 Jan 04, 2018: Sealantis Receives CE Marking For Seal-G Surgical Sealant For GI Procedures
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development
Table 2: Tissue Sealants - Pipeline Products by Segment
Table 3: Tissue Sealants - Pipeline Products by Territory
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date
Table 6: Tissue Sealants - Ongoing Clinical Trials
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development
Table 8: Tissue Sealants - Pipeline Products by Stage of Development
Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: CUTIS - Product Status
Table 11: CUTIS - Product Description
Table 12: VIVO - Product Status
Table 13: VIVO - Product Description
Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Next Generation Internal Fixation And Sealant Device - Product Status
Table 16: Next Generation Internal Fixation And Sealant Device - Product Description
Table 17: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Dural Sealant - Product Status
Table 19: Dural Sealant - Product Description
Table 20: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Hemaseel HMN Fibrin Sealant - Product Status
Table 22: Hemaseel HMN Fibrin Sealant - Product Description
Table 23: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Tisseel Dura - Product Status
Table 25: Tisseel Dura - Product Description
Table 26: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: ClotBlock - Product Status
Table 28: ClotBlock - Product Description
Table 29: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Hydrogel-based Aerosolized Sealant Dressing - Product Status
Table 31: Hydrogel-based Aerosolized Sealant Dressing - Product Description
Table 32: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Progel Dural Sealant - Product Status
Table 34: Progel Dural Sealant - Product Description
Table 35: Progel Emerald - Product Status
Table 36: Progel Emerald - Product Description
Table 37: Tridyne Peripheral - Product Status
Table 38: Tridyne Peripheral - Product Description
Table 39: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Wound Sealant - Product Status
Table 41: Wound Sealant - Product Description
Table 42: Clemson University Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Surgical Adhesive Hydrogel - Product Status
Table 44: Surgical Adhesive Hydrogel - Product Description
Table 45: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Sylys Surgical Sealant - Product Status
Table 47: Sylys Surgical Sealant - Product Description
Table 48: Sylys Surgical Sealant - Drug Delivery - Product Status
Table 49: Sylys Surgical Sealant - Drug Delivery - Product Description
Table 50: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status
Table 51: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description
Table 52: Sylys Surgical Sealant - Orthopedic Procedures - Product Status
Table 53: Sylys Surgical Sealant - Orthopedic Procedures - Product Description
Table 54: Cohera Medical Inc - Ongoing Clinical Trials Overview
Table 55: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant
Table 56: Sylys Surgical Sealant - A Prospective, Randomized, Controlled, Multicenter Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant
Table 57: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Covabond - Product Status
Table 59: Covabond - Product Description
Table 60: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Dural Membrane Sealant - Product Status
Table 62: Dural Membrane Sealant - Product Description
Table 63: Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 64: MeTro - Surgical Glue - Product Status
Table 65: MeTro - Surgical Glue - Product Description
Table 66: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Bioseal Next Gen Device - Product Status
Table 68: Bioseal Next Gen Device - Product Description
Table 69: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: GammaSeal - Product Status
Table 71: GammaSeal - Product Description
Table 72: GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
Table 73: GATT-Spray - Product Status
Table 74: GATT-Spray - Product Description
Table 75: GATT-Tape - Product Status
Table 76: GATT-Tape - Product Description
Table 77: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview
Table 78: SETALUM Sealant - Product Status
Table 79: SETALUM Sealant - Product Description
Table 80: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Fibrin Biological Glue - Product Status
Table 82: Fibrin Biological Glue - Product Description
Table 83: Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Advanced Tissue Sealant - Product Status
Table 85: Advanced Tissue Sealant - Product Description
Table 86: HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Adherus Vascular Sealant - Product Status
Table 88: Adherus Vascular Sealant - Product Description
Table 89: Tissue Plane Sealant - Product Status
Table 90: Tissue Plane Sealant - Product Description
Table 91: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Recombinant Fibrin Glue - Product Status
Table 93: Recombinant Fibrin Glue - Product Description
Table 94: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 95: InVivoSeal - Product Status
Table 96: InVivoSeal - Product Description
Table 97: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Chondroitin Sulfate-based Adhesive - Product Status
Table 99: Chondroitin Sulfate-based Adhesive - Product Description
Table 100: Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Hemostat Sealant - Product Status
Table 102: Hemostat Sealant - Product Description
Table 103: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 104: KUR - 211 - Product Status
Table 105: KUR - 211 - Product Description
Table 106: KUR - 212 - Product Status
Table 107: KUR - 212 - Product Description
1.2 List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development
Figure 2: Tissue Sealants - Pipeline Products by Segment
Figure 3: Tissue Sealants - Pipeline Products by Territory
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Sealants - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report